Viewing StudyNCT06364423



Ignite Creation Date: 2024-05-06 @ 8:23 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06364423
Status: RECRUITING
Last Update Posted: 2024-07-15
First Post: 2024-04-12

Brief Title: Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia CLL
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-18
Start Date Type: ESTIMATED
Primary Completion Date: 2029-07-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2030-07-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-04-12
First Submit QC Date: April 12 2024
Study First Post Date: 2024-04-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-21
Last Update Post Date: 2024-07-15
Last Update Post Date Type: ESTIMATED